Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,161.50    22.50 (1.98%)
Bid:
1,160.50
Ask:
1,161.50
Spread: 1.00 (0.086%)
Market Cap: £9.86b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

29 Aug 2025 10:57

RNS Number : 2505X
Smith & Nephew Plc
29 August 2025
 

SMITH & NEPHEW PLC

 

29 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

1. AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020

 

On 27 August 2025, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted to Ajay Dhankhar under the Smith & Nephew Global Share Plan 2020. The awards have been made in London and are based on the closing Share price on the London Stock Exchange between 6 and 19 August 2025 inclusive, of £13.48.

 

i. PERFORMANCE SHARE PROGRAMME 2025 AWARDS

 

The following Performance Share awards will vest as follows:

 

a. *40,005 shares will vest on 8 March 2027 subject to the achievement of performance conditions measured over the period 1 January 2024 to 31 December 2027; and

b. **87,370 shares will vest on 27 August 2028 subject to the achievement of performance conditions measured over the period 1 January 2025 to 31 December 2028.

 

\* The number of shares subject to the above awards are shown at target vesting. Should maximum vesting be achieved, the participant will receive 2x the number of shares shown above. The participant will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

** The number of shares subject to the above awards are shown at maximum vesting. This award will vest proportionally depending upon the extent to which the associated performance conditions are met. The participant will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

The following relates to the individual included in this section:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Performance Share awards granted at target under the

Smith & Nephew Global Share Plan 2020.

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

127,375

N/A Single Transaction

 

 

ii. SHARE AWARDS

 

One third of the share awards detailed below will vest on 27 August 2026, a further third will vest on 27 August 2027, and the final third will vest on 27 August 2028. Each vesting is subject to Ajay Dhankhar remaining in the employment of the Group on the vesting dates, not being under notice and not having achieved an "unsatisfactory performance" rating for his personal performance in the year prior to each vesting date.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Share awards granted under the Smith & Nephew Global Share Plan 2020.

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

82,572

N/A Single Transaction

 

 

 

2. AWARDS MADE UNDER THE RESTRICTED SHARE PLAN 2024

 

On 27 August 2025, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted to Ajay Dhankhar under the Smith & Nephew Restricted Share Plan 2024. The awards have been made in London and are based on the closing Share price on the London Stock Exchange between 6 and 19 August 2025 inclusive, of £13.48.

 

One third of the Restricted Share awards detailed below will vest on 27 August 2026, a further third will vest on 27 August 2027, and the final third will vest on 27 August 2028. Each vesting is subject to Ajay Dhankhar remaining in the employment of the Group on the vesting dates, not being under notice and not having achieved an "unsatisfactory performance" rating for his personal performance in the year prior to each vesting date.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Restricted Share awards granted under the Smith & Nephew Restricted Share Plan 2024

Date of Transaction

2025 - 08 - 27

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Ajay Dhankhar (Chief Corporate Strategy & Development Officer)

PDMR

Nil

39,359

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFEATVIAFIE
Date   Source Headline
11th May 20212:32 pmRNSHolding(s) in Company
4th May 202112:38 pmRNSTotal Voting Rights
4th May 20219:45 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSTrading Statement
28th Apr 20217:00 amRNSDividend Declaration
14th Apr 20216:04 pmRNSResult of AGM
1st Apr 20211:15 pmRNSTotal Voting Rights
1st Apr 20219:00 amRNSDirector Declaration
31st Mar 202110:00 amRNSAdditional Annual General Meeting update
19th Mar 20211:00 pmRNSDirector/PDMR Shareholding
19th Mar 20219:00 amRNSNotice of Results
17th Mar 20213:30 pmRNSDirector/PDMR Shareholding
10th Mar 20215:45 pmRNSDirector/PDMR Shareholding
9th Mar 20215:48 pmRNSDirector/PDMR Shareholding
8th Mar 202111:30 amRNSDirector/PDMR Shareholding
1st Mar 20214:18 pmRNSAnnual Financial Report
1st Mar 20211:00 pmRNSTotal Voting Rights
18th Feb 20217:00 amRNSFourth Quarter and Full Year 2020 Results
11th Feb 20217:00 amRNSDirector Declaration
10th Feb 20217:00 amRNSJohn Ma joins Smith+Nephew's Board as NED
3rd Feb 20215:00 pmRNSDirector/PDMR Shareholding
1st Feb 20211:41 pmRNSBlock listing Interim Review
1st Feb 202112:30 pmRNSTotal Voting Rights
29th Jan 20217:00 amRNSNotice of Results
28th Jan 20219:15 amRNSDirector Declaration
14th Jan 202111:30 amRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSTrading Statement
6th Jan 20211:00 pmRNSDirectorate Change
4th Jan 20215:46 pmRNSSmith+Nephew Completes Orthopaedics Acquisition
4th Jan 202111:00 amRNSTotal Voting Rights
22nd Dec 20209:00 amRNSDirector/PDMR Shareholding
1st Dec 202012:40 pmRNSTotal Voting Rights
24th Nov 20203:30 pmRNSDirector/PDMR Shareholding
16th Nov 20203:30 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSTotal Voting Rights
3rd Nov 202010:00 amRNSDirector/PDMR Shareholding
2nd Nov 20205:04 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:45 pmRNSTotal Voting Rights
29th Oct 20203:05 pmRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSTrading Statement
20th Oct 202010:00 amRNSKatarzyna Mazur-Hofsaess joins Smith+Nephew as NED
15th Oct 202011:52 amRNSDividend Declaration
9th Oct 20209:08 amRNSNotice of Results
8th Oct 20207:00 amRNSSmith+Nephew Prices USD Bond Issue
1st Oct 202011:08 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTrading Statement
29th Sep 20201:04 pmRNSExtremities Acquisition
15th Sep 20204:56 pmRNSDirector/PDMR Shareholding
10th Sep 202010:26 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.